Therefore, we examined the associations between diabetes and risk of developing prostate cancer defined by clinical features (stage, grade, and lethality) and molecular (TMPRSS2: ERG, PTEN) subtype taking into account screening patterns. The gene discussed is ERG; the disease is prostate carcinoma.